MedPath

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

Phase 2
Completed
Conditions
Critically Ill Children
Interventions
Other: Hospital Standard of Care
Other: Implementation of Bedside Paediatric Early Warning System
Registration Number
NCT01260831
Lead Sponsor
The Hospital for Sick Children
Brief Summary

The purpose of this study is to evaluate the impact of Bedside Paediatric Early Warning System (Bedside-PEWS) on early identification of children at risk for near and actual cardiopulmonary arrest, hospital mortality, processes of care and PICU resource utilization.

Detailed Description

The Bedside Paediatric Early Warning System (Bedside PEWS) is a scientifically developed documentation-based system of care designed to identify children who are clinically deteriorating while admitted to hospital inpatient wards. It was developed and validated by the applicants. The investigators have preliminary data demonstrating that the Bedside PEWS addresses multiple factors (communication, hierarchy, secondary review) contributing to delayed treatment of children at risk. In our pilot study of implementation at a single site the investigators showed statistically significant reductions in late transfers, 'stat' calls, decreased apprehension when nurses called physicians to review patients, and improved communication. Our preliminary data show that the Bedside PEWS score is superior to other methods being used to identify children at risk for impending cardiopulmonary arrest. A 2-year cluster-randomized trial will evaluate the impact of Bedside PEWS on clinical outcomes, processes of care and resource utilization in 22 paediatric hospitals.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
144539
Inclusion Criteria

For Hospitals:

  • provide care for more than 200 inpatient admissions aged <18 years and >37 weeks gestational age in eligible inpatient wards each year
  • have specialised paediatric physicians (including paediatricians, paediatric surgeons, other paediatric sub-specialists) and, one or more intensive care unit (PICU) that provides care for children. A PICU is a designated, staffed area for prolonged mechanical ventilation, invasive monitoring and circulatory support for children- including but not limited to neonates. Other areas designated for patients of increased acuity, such as 'constant observation' or 'high dependency' or 'step-down' units will be regarded as part of the PICU where the PICU staff physicians are wholly or jointly responsible for the care of children in these areas (can write orders in the chart).
  • may or may not have a MET-RRT for children. A MET-RRT is defined as an identified team of one or more trained healthcare professionals who report to an on service PICU physician, and perform urgent consultations on hospital inpatients.

For inpatient wards:

  • areas where care is provided to patients who are admitted to the hospital, other than PICU, operating rooms, and other designated areas where anaesthetist-supervised procedures are performed. All eligible inpatient wards will participate in the study.

For patients:

Within eligible hospitals we will study patients older than 37 weeks gestational age and less than 18 years who are admitted to eligible inpatient wards, who receive care in an eligible inpatient area during the study.

Exclusion Criteria

For hospitals:

  • have plans to introduce a new 'medical emergency team' during the study, and where a severity of illness score (Brighton, Cardiff, PEWS, Bedside PEWS or other unpublished score) is used in ward areas
  • hospitals where randomization is not deemed acceptable. These exclusion criteria ensure that major system changes including introduction of MET-RRT, new documentation systems, physician staffing, and hospital capacity will not bias results.

For patients:

  • those who are less than 37 weeks gestational age throughout their hospitalization
  • are cared for exclusively in an NICU
  • children who are admitted directly to a PICU and die before PICU discharge and thus have not received care in an eligible inpatient ward

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control HospitalsHospital Standard of Carehospitals randomized to continue with their pre existing documentation system (vital sign assessment record)
Intervention HospitalsImplementation of Bedside Paediatric Early Warning Systemhospitals randomized to implement bedsidePEWS documentation system (vital sign assessment record)
Primary Outcome Measures
NameTimeMethod
All Cause Hospital Mortality (Intervention Phase)for 52 weeks starting at Week 31

All cause hospital mortality includes all deaths of eligible inpatients who were cared for in an eligible inpatient ward and will be prospectively assessed for 52 weeks following the 5-week run in period at intervention hospitals.

The following sub-group analyses will be performed: \[1\] Hospital size. Hospitals with \>200 eligible inpatient ward beds will be one group and those with \<200 eligible inpatient ward beds the other. \[2\] Hospitals with and without medical emergency teams. \[3\] Hospitals with ECMO for children. \[4\] patients with urgent PICU admission initiated in an inpatient ward.

Secondary Outcome Measures
NameTimeMethod
Number of Significant Clinical Deterioration Eventsfor 26 weeks starting at Week 0 (baseline) and for 52 weeks starting at week 31 (intervention)

This will be defined as the provision of significant respiratory or circulatory therapies or cardiopulmonary resuscitation in the 12 hours before transfer from inpatient ward, or death without DNR order in an inpatient ward.

The following sub-group analyses will be performed: \[1\] Hospital size. Hospitals with \>200 eligible inpatient ward beds will be one group and those with \<200 eligible inpatient ward beds the other. \[2\] Hospitals with and without medical emergency teams. \[3\] Hospitals with ECMO for children. \[4\] patients with urgent PICU admission initiated in an inpatient ward.

Trial Locations

Locations (22)

HUDERF: Queen Fabiola Children's University Hospital

๐Ÿ‡ง๐Ÿ‡ช

Brussels, Belgium

Alberta Children's Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

Calgary, Alberta, Canada

Stollery Children's Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

Edmonton, Alberta, Canada

IWK Health Centre

๐Ÿ‡จ๐Ÿ‡ฆ

Halifax, Nova Scotia, Canada

London Health Sciences Center University Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

London, Ontario, Canada

McMaster Children's Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

Hamilton, Ontario, Canada

Centre hospitalier universitaire Sainte-Justine

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

The Hospital for Sick Children

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

Montreal Children's Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

Children's University Hospital

๐Ÿ‡ฎ๐Ÿ‡ช

Dublin, Ireland

Centre hospitalier universitaire de Quรฉbec (CHUQ)

๐Ÿ‡จ๐Ÿ‡ฆ

Quebec, Canada

Bambino Gesรน Children's Hospital

๐Ÿ‡ฎ๐Ÿ‡น

Rome, Italy

Our Lady's Children's Hospital

๐Ÿ‡ฎ๐Ÿ‡ช

Dublin, Ireland

Erasmus MC-Sophia

๐Ÿ‡ณ๐Ÿ‡ฑ

Rotterdam, Netherlands

Starship Children's Health

๐Ÿ‡ณ๐Ÿ‡ฟ

Auckland, New Zealand

Barts Health - The London NHS Trust

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Kings College Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

St. George's Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

St. Mary's Hospital - Imperial College Healthcare

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Victoria General Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

Victoria, British Columbia, Canada

Saint John Regional Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

Saint John, New Brunswick, Canada

Royal Brompton Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

ยฉ Copyright 2025. All Rights Reserved by MedPath